Audit in process? Call the number on your audit letter to get options.
Site Logo
Health care professionals website
DPL Global Search
DPL Utility Nav
DPL Main Nav
DPL Global Search
DPL Utility Nav
Breadcrumbs
SubHero Banner
RxNews®
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Cymbalta® (duloxetine) – Expanded indication
April 20, 2020 - The FDA approved Eli Lilly’s Cymbalta (duloxetine), for the treatment of fibromyalgia in adults and pediatric patients 13 years of age and older.
